Inside FDA, career staffers describe how political pressure is influencing their work

Taking stock of the drug industry, from the lab to the medicine chest

October 14, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Andrew Harnik/Getty Images STAT+ | Inside FDA, career staffers describe how political pressure is influencing their work Current and former FDA staff said the degree of involvement of political officials in nitty-gritty regulatory matters, from autism to vaccines, is unprecedented. By Lizzy Lawrence STAT+ | Kailera Therapeutics, an obesity drug startup, raises $600 million The deal points to persistent heightened attention to obesity drugs, even after multiple years of activity and some clinical disappointments. By Allison DeAngelis STAT+ | FDA declares Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance The move could further delay the approval of drugs made by some biotechs, including some from Scholar Rock and Regeneron Pharmaceuticals. By Elaine Chen Adobe Opinion: Drug developers shouldn't shortchange the autoimmune community Trial participants deserve financial and logistical help, radical transparency, and honesty about benefits and risks. By Paul J. Hastings

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser